©2026 Bryn Mawr Communications, LLC.
All Rights Reserved

Terms and Conditions • Privacy Policy

iStent Inject With Premium IOL Implantation

Inder Paul Singh, MD

Show Description +

Inder Paul Singh, MD, demonstrates use of the iStent inject (Glaukos) following implantation of a Trulign Toric lens (Bausch + Lomb) and explains that use of this MIGS device does not impact the predicability of refractive measurements. This patient was on two medications preoperatively with an IOP of 18 mmHg and was 14 mmHg with 20/25 vision one day postoperatively.

Posted: 3/21/2019

Keywords:

Glaukos Corporation

•

Inder Paul Singh, MD

•

iStent

•

iStent Inject

•

Microinvasive Glaucoma Surgery (MIGS)

•

Microinvasive Glaucoma Surgery (MIGS)

•

Premium IOLs

Up Next

FLACS With Toric and iStent inject
FLACS With Toric and iStent inject

Blake Williamson, MD, MPH, MS

Targeted Placement of iStent Trabecular Micro-Bypass Stent (Glaukos)
Targeted Placement of iStent Trabecular Micro-Bypass Stent (Glaukos)

Eric Rosenberg, MD

Cataract Surgery Combined with Canaloplasty
Cataract Surgery Combined with Canaloplasty

Mahmoud A. Khaimi, MD

Needle Viscocanalostomy
Needle Viscocanalostomy

Eslam Ramadan, MD

Ahmed M4 Placement
Ahmed M4 Placement

Nathan Radcliffe MD

Hydrogel Sealant to Prevent Chamber Shallowing During Combined Phaco and Tube Shunt Insertion
Hydrogel Sealant to Prevent Chamber Shallowing During Combined Phaco and Tube Shunt Insertion

Ian Conner, MD

Supra-Tenons Baerveldt Glaucoma Drainage Device
Supra-Tenons Baerveldt Glaucoma Drainage Device

George Tanaka, MD

iStent Trabecular Microbypass Implantation Technique
iStent Trabecular Microbypass Implantation Technique

Ike K. Ahmed MD

Trabectome 180
Trabectome 180

Constance Okeke, MD, MSCE

New Directions for GT
New Directions for GT

Arsham Sheybani, MD, Iqbal Ike K. Ahmed, MD, FRCSC

iStent Inject With Premium IOL Implantation

Inder Paul Singh, MD

Inder Paul Singh, MD, demonstrates use of the iStent inject (Glaukos) following implantation of a Trulign Toric lens (Bausch + Lomb) and explains that use of this MIGS device does not impact the predicability of refractive measurements. This patient was on two medications preoperatively with an IOP of 18 mmHg and was 14 mmHg with 20/25 vision one day postoperatively.

Posted: 3/21/2019

Keywords:

Glaukos Corporation

•

Inder Paul Singh, MD

•

iStent

•

iStent Inject

•

Microinvasive Glaucoma Surgery (MIGS)

•

Microinvasive Glaucoma Surgery (MIGS)

•

Premium IOLs

Please log in to leave a comment.

More in Glaucoma

Academy IRIS® Registry Data Outcomes on Gel Stent Use
Academy IRIS® Registry Data Outcomes on Gel Stent Use

Arsham Sheybani, MD

A Monocular Patient With Significant OSD and Worsening Visual Acuity
A Monocular Patient With Significant OSD and Worsening Visual Acuity

John P. Berdahl, MD; Tanner J. Ferguson, MD; and Mitch Ibach, OD, FAAO

Excimer Laser Treatment for Open-Angle Glaucoma
Excimer Laser Treatment for Open-Angle Glaucoma

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Mark J. Gallardo, MD

Angle-Based MIGS for a Patient With Severe Glaucoma
Angle-Based MIGS for a Patient With Severe Glaucoma

John P. Berdahl, MD; Tanner J. Ferguson, MD; and Mitch Ibach, OD, FAAO

close-x